Vaccination in Inflammatory Rheumatic Diseases.
10.4078/jrd.2013.20.4.218
- Author:
Chung Il JOUNG
1
Author Information
1. Divison of Rheumatology, Konyang University Hospital, Daejeon, Korea. cij1221@hanafos.com
- Publication Type:Review
- Keywords:
Vaccination;
Recommendation;
Inflammatory Rheumatic diseases
- MeSH:
Adult;
Child;
Humans;
Influenza, Human;
Pneumococcal Vaccines;
Rheumatic Diseases;
Rheumatology;
Vaccination;
Vaccines, Attenuated
- From:Journal of Rheumatic Diseases
2013;20(4):218-222
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Infection is a critical and challenging situation encountered in treatment of inflammatory rheumatic diseases (IRDs). It is associated with the disease activity itself and/or the immunosuppressant treatments. Vaccine preventable infections could be controlled by use of a timely vaccination protocol. Immunosuppressed situations observed in IRDs require some modification of the recommendation for the general population in each national society. Live attenuated vaccines are generally contraindicated in IRDs, except for varicella-zoster vaccination, which is solely permitted live vaccine and could be given on a case by case basis in autoimmune IRDs. Influenza and pneumococcal vaccines are strongly recommended due to increased mortality in patients with IRDs. The vaccination protocol reflects the current national medical environment and requirements; therefore, it could change with time. The Korean Rheumatology Society now requires that vaccination be recommended for patients with IRDs, with the possibility of both an adult and child version.
